Furthermore, since GBM has a high proliferative index and rarely metastasizes outside the CNS, and given that the brain is essentially a post-mitotic structure, accumulating high doses of a KIF11 inhibitor in brain would essentially target all GBM cells with relatively little CNS toxicity. Here, KIF11 is linked to glioblastoma.